Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Letrozole × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 372 Polycystic Ovary Syndrome 40 Endometrial Neoplasms 22 Neoplasm Metastasis 21 Ovarian Neoplasms 16 Neoplasms 14 Infertility 11 Advanced Breast Cancer 10 Fallopian Tube Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Recurrence 7 Osteoporosis 7 Carcinoma, Ductal, Breast 7 Breast Neoplasms, Male 7 Breast Diseases 7 Triple Negative Breast Neoplasms 6 Carcinoma, Lobular 6 Breast Carcinoma In Situ 6 Prostatic Neoplasms 4 Leiomyoma 4 Infertility, Female 4 Hereditary Sensory and Autonomic Neuropathies 4 Breast Cancer Metastatic 4 Arthralgia 4 Obesity 3 Neoplasms, Hormone-Dependent 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2

Interventions

Cyclophosphamide 23 blinatumomab 18 Cytarabine 15 fludarabine 13 Azacitidine 12 venetoclax 10 fludarabine phosphate 10 Rituximab 8 Blood Specimen Collection 8 Methotrexate 7 Lenalidomide 7 Dexamethasone 7 Daunorubicin 7 Mercaptopurine 6 Vincristine 5 daratumumab 4 Whole-Body Irradiation 4 Melphalan 4 Idarubicin 4 Etoposide 4 Drug Therapy 4 Busulfan 4 pembrolizumab 3 obinutuzumab 3 Radiotherapy 3 Liquid Biopsy 3 Immunotherapy, Adoptive 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Doxorubicin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04130152 2022-10-25

PROMETEO II

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡